FDA ALERT
FDA ALERT
11/15/2023
Jessica Ganga
In late September, the FDA approved the first biosimilar to tocilizumab to treat adult and pediatric patients with various indications of arthritis.
11/15/2023
Treatment
Treatment
06/17/2020
The drug was given priority review status by the FDA and was approved to treat adults with the rare, severe autoimmune disease.
06/17/2020